Loading clinical trials...
Loading clinical trials...
Double Blind, Non-inferiority Study to Evaluate the Antidepressant Activity of ETS6103 Compared to Amitriptyline in Treating Major Depressive Disorder in Patients With Unsatisfactory Response to Selective Serotonin Re-uptake Inhibitors.
Conditions
Interventions
ETS6103 (low dose)
ETS6103 (high dose)
+1 more
Locations
1
United Kingdom
CPS Research
Glasgow, Scotland, United Kingdom
Start Date
October 1, 2013
Primary Completion Date
October 1, 2015
Completion Date
October 1, 2015
Last Updated
January 11, 2017
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT07329621
Lead Sponsor
e-Therapeutics PLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions